Risk is inherent to cannabis operations, regardless of cannabinoid profile. That risk extends to retail end users that are consuming products that aren’t extensively researched, from processes that aren’t sufficiently regulated. Delta-8 THC (∆8THC) is a prime example, but one that many readers will distance themselves from. It has had far more impact on cannabinoid markets than CBD or CBG in the last year.
Shipping extracts with any amount of ∆9THC has been the primary risk to hemp operators to date, and previous Hemp Bulletin commentary has illustrated that risk through stories like the unfortunate episode with
11.22.2024
Biodiesel margins rise, but window of opportunity limited
Biodiesel margins continued to rise during the week to Friday November 22. The bean oil/heating oil (BOHO) spread boosted margins by falling to its lowest level since August 27.
11.22.2024
Gulf prices average higher despite weeklong declines in SBO
For the week ended Friday November 22, packer bleachable fancy tallow (BFT) remained unchanged from the previous week’s average, while Gulf Coast-delivered tallow rose 2.7%, primarily...
11.22.2024
Bloodmeal largest price mover week on week; November cattle on feed higher
US animal protein prices were mixed to mostly higher for the week to Friday November 22, with only meat and bonemeal showing a slight price reduction due to tighter...